{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T12:43:18Z","timestamp":1772282598220,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"am","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA072720"],"award-info":[{"award-number":["P30CA072720"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.urology.2024.08.067","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T16:38:35Z","timestamp":1725295115000},"page":"289-294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Early Adjuvant Chemotherapy Improves Survival in Muscle Invasive Bladder Cancer: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"194","author":[{"given":"Shane","family":"Kronstedt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gal","family":"Saffati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Hinojosa-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sai Krishnaraya","family":"Doppalapudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Chua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas L.","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni E.","family":"Cacciamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saum","family":"Ghodoussipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2024.08.067_bib1","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2024.08.067_bib2","article-title":"Neoadjuvant chemotherapy for invasive bladder cancer","volume":"2004","author":"Advanced Bladder Cancer Overview Collaboration","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.urology.2024.08.067_bib3","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1464-410X.2012.11424.x","article-title":"A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer","volume":"111","author":"Mitra","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2024.08.067_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.juro.2013.07.061","article-title":"Refining patient selection for neoadjuvant chemotherapy before radical cystectomy","volume":"191","author":"Culp","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2024.08.067_bib5","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1002\/cncr.32048","article-title":"Delays in radical cystectomy for muscle-invasive bladder cancer","volume":"125","author":"Chu","year":"2019","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.urology.2024.08.067_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.eururo.2021.09.028","article-title":"Adjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and meta-analysis of individual participant data from randomised controlled trials","volume":"81","author":"Advanced Bladder Cancer (ABC) Meta-analysis Collaborators Group","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2024.08.067_bib7","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa2034442","article-title":"Adjuvant nivolumab versus placebo in muscle-invasive urothelial carcinoma","volume":"384","author":"Bajorin","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2024.08.067_bib8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.juro.2014.01.097","article-title":"Enhanced recovery protocol after radical cystectomy for bladder cancer","volume":"192","author":"Daneshmand","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2024.08.067_bib9","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.eururo.2016.05.031","article-title":"Enhanced recovery pathways versus standard care after cystectomy: a meta-analysis of the effect on perioperative outcomes","volume":"70","author":"Tyson","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2024.08.067_bib10","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","year":"2020"},{"key":"10.1016\/j.urology.2024.08.067_bib11","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/annonc\/mdu204","article-title":"Delivery of perioperative chemotherapy for bladder cancer in routine clinical practice","volume":"25","author":"Booth","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urology.2024.08.067_bib12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.urology.2019.05.038","article-title":"Survival benefit persists with delayed initiation of adjuvant chemotherapy following radical cystectomy for locally advanced bladder cancer","volume":"132","author":"Corbett","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.urology.2024.08.067_bib13","first-page":"934.e1","article-title":"Impact of timing of adjuvant chemotherapy following radical cystectomy for bladder cancer on patient survival","volume":"38","author":"Grunewald","year":"2020","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"10.1016\/j.urology.2024.08.067_bib14","first-page":"75.e15","article-title":"Timing of adjuvant chemotherapy and overall survival following radical cystectomy","volume":"38","author":"Jue","year":"2020","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"10.1016\/j.urology.2024.08.067_bib15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1470-2045(14)71160-X","article-title":"Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial","volume":"16","author":"Sternberg","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.urology.2024.08.067_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.critrevonc.2005.05.004","article-title":"Perioperative chemotherapy for bladder cancer","volume":"57","author":"Sonpavde","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.urology.2024.08.067_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.eururo.2008.07.018","article-title":"Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience","volume":"55","author":"Donat","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2024.08.067_bib18","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41586-021-03642-9","article-title":"ctDNA guiding adjuvant immunotherapy in urothelial carcinoma","volume":"595","author":"Powles","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.urology.2024.08.067_bib19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1470-2045(21)00004-8","article-title":"Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial","volume":"22","author":"Bellmunt","year":"2021","journal-title":"Lancet Oncol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429524007702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429524007702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T15:01:23Z","timestamp":1733324483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429524007702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":19,"alternative-id":["S0090429524007702"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2024.08.067","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Adjuvant Chemotherapy Improves Survival in Muscle Invasive Bladder Cancer: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2024.08.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}